跳至主要内容
临床试验/CTRI/2025/01/079767
CTRI/2025/01/079767尚未招募Phase 3 4

The comparative effectiveness between Individualised Homoeopathic Medicines and Calcarea Phosphorica 6X in cases of Vitamin D deficiency or insufficiency; An open-label, randomised clinical trial

未提供1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年2月19日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
入组人数
60
试验地点
1
主要终点
Serum Vitamin D-25(OH) testing using Chemiluminescence Immunoassay (CLIA) technique

研究概览

简要总结

Total study duration is for a period of 18 months and each patient will be studied for a period of 3 months. Serum Vitamin D-25(OH) and serum calcium levels of each patient will be measured at baseline and after a period of 3 months. One arm will be given Calcarea Phosphorica 6x and another Individualised Homoeopathic Medicines out of which patients are selected randomly. Since it is an open study the researcher and patient are both aware of medication given. Patients are selected based on the inclusion and exclusion criteria as described. The total sample size is of 60 including a 20% dropout. The effectiveness of Calcarea Phosphorica 6x and Individualised Homoeopathic Medicines will be studied in this study. in case of any adverse events they will be recorded and reported as required.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
10.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with serum Vitamin D-25(OH) less than 30ng per mL Patients of all religions and races irrespective of socioeconomic status Patients willing to take part in the study and for regular follow ups Patients who are willing to fill the respective consent forms.

排除标准

  • Patients with severe hepatic and renal diseases Patients with serum Vitamin D-25(OH) less than 5ng per mL Pregnant and lactating women.
  • Patients not willing to take part in study and regular follow ups.
  • Patients having any terminal disease condition.
  • Patients taking Vitamin D supplements or allopathic medicines for Vitamin D deficiency.
  • Patients taking Homoeopathic medicines within the last one month.

结局指标

主要结局

Serum Vitamin D-25(OH) testing using Chemiluminescence Immunoassay (CLIA) technique

时间窗: at baseline and after a period of 3 months

次要结局

  • Serum Calcium testing(at baseline and after a period of 3 months)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Gurjeev Singh AL Gurcharan Singh

National Institute of Homoeopathy

研究点 (1)

Loading locations...

相似试验